Sawase, Hironori
Ozawa, Eisuke
Yano, Hiroshi
Ichinomiya, Taiga
Yano, Rintaro
Miyaaki, Hisamitsu
Komatsu, Naohiro
Ayuse, Takao
Kurata, Shinji
Sato, Shuntaro
Pinkham, Maximilian Ichabod
Tatkov, Stanislav
Ashizawa, Kazuto
Nagata, Kazuyoshi
Nakao, Kazuhiko
Article History
Received: 19 December 2022
Accepted: 4 May 2023
First Online: 8 May 2023
Declarations
:
: The study was conducted at Nagasaki University Hospital with the approval of Nagasaki University’s Clinical Research Review Board (CRB7180001) and written informed consent was obtained from all subjects participating in this study. This clinical trial was registered prior to patient enrollment in the Japan Registry of Clinical Trials (jRCTs072190021; Principal investigator: Takao Ayuse; Date of registration: August 26, 2019). All methods were carried out in accordance with relevant guidelines and regulations (Declaration of Helsinki).
: Not applicable
: The authors declare no competing interests.